MPCT Hospital Management is pleased to announce that it has received approval from Bhabha Atomic Research Center (BARC) for low dose radiation therapies by radioactive iodine in the treatment of hyperfunctioning thyroid and Samarium & phosphorus for bone pain palliation. While announcing the news the team of experts highlighted the significance and effectiveness of Radioactive Iodine in curing Thyroid Cancer and the necessity to educate people about the importance of thyroid health and the medical advancement attained in treating thyroid diseases.
Dr. Prince Surana, the CEO, Surana Group of Hospitals, said, “Number of people suffering from cancer has seen a rise in recent years. The good news is that most of these cancer cases are treatable. Mostly surgical removal of all or part of the thyroid & lymph nodes is undertaken during treatment. But now, Radioactive Iodine is useful to kill cancer cells that may have left behind during surgical removal or spread in the body or the thyroid cancer that may reappear after treatment. It has become a real blessing for thyroid cancer patients.” He further added, “Spreading awareness about the early and accurate diagnosis, right and timely treatment with modern therapies and consistent follow-ups are the keys that can help free the world from diseases such as thyroid cancer.”
Radioactive Iodine & Thyroid Cancer Some Facts
The thyroid gland is located in the lower part of the neck which secretes hormones that supply energy to body cells and regulates metabolism. Malfunction of the thyroid gland may lead to various types of diseases such as hyperthyroidism, hypothyroidism, thyroiditis, benign lumps, goiter, immune thyroid disease, and thyroid cancer. These thyroid diseases have become common worldwide. According to the reports of Indian Thyroid Society, around 4.2 Crore Indians are suffering from a thyroid disorder, out of which almost 90% of patients are undiagnosed. Further, it stated that thyroid cancer is the most common endocrine malignancy with symptoms like pain in the lower front portion of the neck, a lump in the neck, swollen lymph nodes in the neck, harshness of voice, and difficulty in breathing and swallowing. Further medical investigations such as physical examination, blood tests, thyroid scans & ultrasound along with other body scans, fine-needle aspiration biopsy and surgical biopsy are used to detect thyroid cancer in a patient showing symptoms of thyroid cancer. In most of the thyroid cancer treatments, the complete thyroid is removed and the patients need to take thyroid replacement hormone during their lives. In some cases, the Lymph nodes in the patient’s neck containing cancer cells are also removed. After the surgery, Radioactive Iodine therapy is given to the patients to destroy any cancer cells that may have been left behind. During this therapy, the cancerous cells take up the Radioactive Iodine which kills cancer cells.
Radioactive Iodine Therapy in Mumbai
Radioactive Iodine Therapy in Mumbai is now available at MPCT Cancer Hospital in Mumbai with specialized infrastructure requirement such as isolation rooms and separate drainage system, etc. “The advancement in radioactive therapy can save a person’s life by destroying microscopic cancer cells and even helps patients whose thyroid cancer returns after surgery. In case of patients who have several enlarged nodes, have chances of cancer cells being left behind and therefore requiring Radioactive Iodine Therapy. Patients are kept under observation in isolation wards after Radioactive Iodine therapy to check the radiation levels,” Said expert oncologist at MPCT Cancer Hospital. MPCT is leading cancer hospital in Mumbai with world-class oncology and radiation treatment options available at affordable cost, he added.
Even treatment is possible for most types of thyroid cancer, there are limited treatment alternatives available once thyroid cancer has progressed; therefore it remains a disease with significant unmet medical needs. We, at MPCT hospital, are committed to exploring further benefits of advanced treatments in the field of oncology to further contribute to patients suffering from cancer and their families.